226 related articles for article (PubMed ID: 16302157)
1. D-dimer, oral anticoagulation, and venous thromboembolism recurrence.
Cosmi B; Palareti G
Semin Vasc Med; 2005 Nov; 5(4):365-70. PubMed ID: 16302157
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
[TBL] [Abstract][Full Text] [Related]
3. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
Palareti G; Legnani C; Cosmi B; Guazzaloca G; Pancani C; Coccheri S
Thromb Haemost; 2002 Jan; 87(1):7-12. PubMed ID: 11848459
[TBL] [Abstract][Full Text] [Related]
4. [Current criteria to determine the duration of anticoagulant therapy].
Palareti G
Recenti Prog Med; 2007 Dec; 98(12):603-6. PubMed ID: 18369033
[TBL] [Abstract][Full Text] [Related]
5. Oral anticoagulant therapy in venous thromboembolism.
Cosmi B; Palareti G
Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
[TBL] [Abstract][Full Text] [Related]
6. D-dimer and factor VIII are independent risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis.
Cosmi B; Legnani C; Cini M; Favaretto E; Palareti G
Thromb Res; 2008; 122(5):610-7. PubMed ID: 18304616
[TBL] [Abstract][Full Text] [Related]
7. D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis.
Cosmi B; Legnani C; Cini M; Guazzaloca G; Palareti G
Thromb Haemost; 2005 Nov; 94(5):969-74. PubMed ID: 16363238
[TBL] [Abstract][Full Text] [Related]
8. Update on the predictive value of D-dimer in patients with idiopathic venous thromboembolism.
Cosmi B; Palareti G
Thromb Res; 2010 Apr; 125 Suppl 2():S62-5. PubMed ID: 20434008
[TBL] [Abstract][Full Text] [Related]
9. Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG study.
Cosmi B; Legnani C; Tosetto A; Pengo V; Ghirarduzzi A; Testa S; Prisco D; Poli D; Tripodi A; Palareti G; ;
Thromb Haemost; 2010 Jun; 103(6):1152-60. PubMed ID: 20352167
[TBL] [Abstract][Full Text] [Related]
10. D-dimer testing to determine the duration of anticoagulant therapy.
Palareti G; Cosmi B; Legnani C
Curr Opin Pulm Med; 2007 Sep; 13(5):393-7. PubMed ID: 17940483
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism: risk factors for recurrence.
Zhu T; Martinez I; Emmerich J
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
[TBL] [Abstract][Full Text] [Related]
12. What is the optimal duration of treatment for DVT? An update on evidence-based medicine of treatment for DVT.
East AT; Wakefield TW
Semin Vasc Surg; 2010 Sep; 23(3):182-91. PubMed ID: 20826296
[TBL] [Abstract][Full Text] [Related]
13. Potential use of D-dimer measurement in patients treated with oral anticoagulant for a venous thromboembolic episode.
Ombandza-Moussa E; Samama MM; Horellou MH; Elalamy I; Conard J
Int Angiol; 2003 Dec; 22(4):364-9. PubMed ID: 15153820
[TBL] [Abstract][Full Text] [Related]
14. 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII.
Eischer L; Gartner V; Schulman S; Kyrle PA; Eichinger S;
Ann Hematol; 2009 May; 88(5):485-90. PubMed ID: 18931845
[TBL] [Abstract][Full Text] [Related]
15. D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis.
Cosmi B; Legnani C; Cini M; Guazzaloca G; Palareti G
Thromb Haemost; 2011 May; 105(5):837-45. PubMed ID: 21359409
[TBL] [Abstract][Full Text] [Related]
16. The negative predictive value of D-dimer on the risk of recurrent venous thromboembolism in patients with multiple previous events: a prospective cohort study (the PROLONG PLUS study).
Ageno W; Cosmi B; Ghirarduzzi A; Santoro R; Bucherini E; Poli D; Prisco D; Alatri A; Pengo V; Galli L; Dentali F; Palareti G
Am J Hematol; 2012 Jul; 87(7):713-5. PubMed ID: 22488507
[TBL] [Abstract][Full Text] [Related]
17. How should we determine length of anticoagulation after proximal deep vein thrombosis of the lower limbs?
Siragusa S; Caramazza D; Malato A
Br J Haematol; 2009 Mar; 144(6):832-7. PubMed ID: 19183183
[TBL] [Abstract][Full Text] [Related]
18. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
[TBL] [Abstract][Full Text] [Related]
19. Extended treatment for venous thromboembolism: how long is long enough?
Cosmi B; Palareti G
Curr Hematol Rep; 2004 Sep; 3(5):375-81. PubMed ID: 15341706
[TBL] [Abstract][Full Text] [Related]
20. [High negative predictive value for recurrence of venous thromboembolism with d-dimer carried out three months after the suspension of treatment with oral anticoagulants in patients over 60].
Palareti G; Guazzaloca G; Legnani C; Fortunato G; Grauso F; De Rosa V; Rodorigo G; Cosmi B; Coccheri S
Minerva Cardioangiol; 1998 Oct; 46(10):374-5. PubMed ID: 10021815
[No Abstract] [Full Text] [Related]
[Next] [New Search]